Sunday 24 December 2017
Biotech startups choosy on deals with big pharma: Bayer executive
MUMBAI: Awash with financing options from venture capital firms, the best of the biotech startups are at a pole position, getting picky and pricey about deals with their larger pharma peers, Kemal Malik, who helms the global innovations unit at Bayer, the $55-billion German healthcare-to-agriculture
You can read more here: Biotech startups choosy on deals with big pharma: Bayer executive
Subscribe to:
Post Comments (Atom)
Life insurers earn more in Oct selling lesser policies
The 24-company Indian life insurance industry closed last month with new business of Rs 22,776.03 crore, up by 31.87 per cent over the prev...
-
When Ahm Sari started woodworking as a hobby, everyone told him that hide glue was far and away the best glue he could use. However, as a d...
-
The 24-company Indian life insurance industry closed last month with new business of Rs 22,776.03 crore, up by 31.87 per cent over the prev...
No comments:
Post a Comment